2721-84-8

Basic information

• Product Name: N-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)acetamide
• Synonyms: acetamide, N-(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)-
• CAS NO: 2721-84-8
• Molecular Formula: C₁₂H₁₃N₃O₂
• Molecular Weight: 231.2505
• Mol File: 2721-84-8.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 505.1°C at 760 mmHg
• Flash Point: 259.3°C
• Density: 1.27g/cm³
• Vapor Pressure: 2.51E-10mmHg at 25°C
• Refractive Index: 1.623
• CAS DataBase Reference: N-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)acetamide(2721-84-8)
• EPA Substance Registry System: N-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)acetamide(2721-84-8)

Safety Data

• Hazardous Substances Data: 2721-84-8(Hazardous Substances Data)

Downstream Products

• 2721-85-9 3,5-dimethyl-1-phenyl-1H-pyrazolo[4,3-d]thiazole 

Relevant articles and documents

Detection and Treatment of Schizophrenia

The present invention provides a method for diagnosing schizophrenia, and a schizophrenia diagnostic reagent or device for use in the method. The present invention further provides a therapeutic or ameliorating agent for schizophrenia, which is effective for the treatment or amelioration of schizophrenia. The therapeutic or ameliorating agent for schizophrenia contains a carbonyl scavenger or a carbonyl-modified protein formation inhibitor as an active ingredient. The method for diagnosing schizophrenia according to the present invention includes measuring at least one parameter in a subject, the parameter being selected from the group consisting of: (1) a genetic abnormality of glyoxalase I gene; (2) the expression level or activity of glyoxalase I in a biological sample; (3) the amount of a carbonyl compound or a carbonyl-modified protein that is a protein modified with the carbonyl compound; and (4) the amount of pyridoxal in a biological sample.